These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35422159)

  • 1. Re-randomisation trials in multi-episode settings: Estimands and independence estimators.
    Kahan BC; White IR; Hooper R; Eldridge S
    Stat Methods Med Res; 2022 Jul; 31(7):1342-1354. PubMed ID: 35422159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independence estimators for re-randomisation trials in multi-episode settings: a simulation study.
    Kahan BC; White IR; Eldridge S; Hooper R
    BMC Med Res Methodol; 2021 Oct; 21(1):235. PubMed ID: 34717559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informative cluster size in cluster-randomised trials: A case study from the TRIGGER trial.
    Kahan BC; Li F; Blette B; Jairath V; Copas A; Harhay M
    Clin Trials; 2023 Dec; 20(6):661-669. PubMed ID: 37439089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimands in cluster-randomized trials: choosing analyses that answer the right question.
    Kahan BC; Li F; Copas AJ; Harhay MO
    Int J Epidemiol; 2023 Feb; 52(1):107-118. PubMed ID: 35834775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking intercurrent events in defining estimands for tuberculosis trials.
    Pham TM; Tweed CD; Carpenter JR; Kahan BC; Nunn AJ; Crook AM; Esmail H; Goodall R; Phillips PP; White IR
    Clin Trials; 2022 Oct; 19(5):522-533. PubMed ID: 35850542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A re-randomisation design for clinical trials.
    Kahan BC; Forbes AB; Doré CJ; Morris TP
    BMC Med Res Methodol; 2015 Nov; 15():96. PubMed ID: 26541982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimands for factorial trials.
    Kahan BC; Morris TP; Goulão B; Carpenter J
    Stat Med; 2022 Sep; 41(22):4299-4310. PubMed ID: 35751568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
    Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
    Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using modified intention-to-treat as a principal stratum estimator for failure to initiate treatment.
    Kahan BC; White IR; Edwards M; Harhay MO
    Clin Trials; 2023 Jun; 20(3):269-275. PubMed ID: 36916466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
    Rehal S; Cro S; Phillips PP; Fielding K; Carpenter JR
    Clin Trials; 2023 Oct; 20(5):497-506. PubMed ID: 37277978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimands in published protocols of randomised trials: urgent improvement needed.
    Kahan BC; Morris TP; White IR; Carpenter J; Cro S
    Trials; 2021 Oct; 22(1):686. PubMed ID: 34627347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands.
    Cro S; Kahan BC; Rehal S; Chis Ster A; Carpenter JR; White IR; Cornelius VR
    BMJ; 2022 Aug; 378():e070146. PubMed ID: 35998928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.
    Aroda VR; Saugstrup T; Buse JB; Donsmark M; Zacho J; Davies MJ
    Diabetes Obes Metab; 2019 Oct; 21(10):2203-2210. PubMed ID: 31168921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool.
    Cro S; Kahan BC; Patel A; Henley A; C J; Hellyer P; Kumar M; Rahman Y; Goulão B
    Trials; 2023 Jul; 24(1):443. PubMed ID: 37408080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
    Foley JF; Defer G; Ryerson LZ; Cohen JA; Arnold DL; Butzkueven H; Cutter G; Giovannoni G; Killestein J; Wiendl H; Smirnakis K; Xiao S; Kong G; Kuhelj R; Campbell N;
    Lancet Neurol; 2022 Jul; 21(7):608-619. PubMed ID: 35483387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.
    Rake C; Gilham C; Bukasa L; Ostler R; Newton M; Peto Wild J; Aigret B; Hill M; Gillie O; Nazareth I; Sasieni P; Martineau A; Peto J
    Health Technol Assess; 2020 Feb; 24(10):1-54. PubMed ID: 32090730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating estimands into clinical trial statistical analysis plans.
    Kang M; Kendall MA; Ribaudo H; Tierney C; Zheng L; Smeaton L; Lindsey JC
    Clin Trials; 2022 Jun; 19(3):285-291. PubMed ID: 35257600
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.